NRx’s COVID-19 Vaccine Candidate BriLife Impresses In Phase II

Promising Delta Variant Antibody Levels

 
• By Ayisha Sharma
  
BriLife Is A Live Vaccine • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip